Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Christopher A. Posner$20M
Market Cap • 25/07/20242004
(há 20 anos)
2014
(10 years ago)
NASDAQ
Listagem
Stamford
Sede • Connecticut106
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CARASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.